Development of a Retinal-Based Probe for the Profiling Of
This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. Research Article Cite This: ACS Cent. Sci. 2019, 5, 1965−1974 http://pubs.acs.org/journal/acscii Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells † # ‡ § † Sebastiaan T. A. Koenders, , Lukas S. Wijaya, Martje N. Erkelens, Alexander T. Bakker, ‡ † ∥ † † Vera E. van der Noord, Eva J. van Rooden, Lindsey Burggraaff, Pasquale C. Putter, Else Botter, † # ⊥ † ⊥ ‡ Kim Wals, , Hans van den Elst, Hans den Dulk, Bogdan I. Florea, Bob van de Water, ∥ § ⊥ ‡ Gerard J. P. van Westen, Reina E. Mebius, Herman S. Overkleeft, Sylvia E. Le Devédec,́ † # and Mario van der Stelt*, , † Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden 2300 RA, The Netherlands ‡ Cancer Therapeutics and Drug Safety, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden 2300 RA, The Netherlands § Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centra, Amsterdam 1081 HV, The Netherlands ∥ Computational Drug Discovery, Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden 2300 RA, The Netherlands ⊥ Department of Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden 2300 RA, The Netherlands # Oncode Institute, Utrecht 3521 AL, The Netherlands *S Supporting Information ABSTRACT: Retinaldehyde dehydrogenases belong to a superfamily of enzymes that regulate cell differentiation and are responsible for detoxification of anticancer drugs.
[Show full text]